POU1F1 Antibody / PIT-1 / GHF-1, Clone: [PIT1/7262], Mouse, Monoclonal

Artikelnummer: NSJ-V4044-20UG
Artikelname: POU1F1 Antibody / PIT-1 / GHF-1, Clone: [PIT1/7262], Mouse, Monoclonal
Artikelnummer: NSJ-V4044-20UG
Hersteller Artikelnummer: V4044-20UG
Alternativnummer: NSJ-V4044-20UG
Hersteller: NSJ Bioreagents
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC-P
Spezies Reaktivität: Human
Immunogen: Recombinant human full-length protein was used as the immunogen for the POU1F1 antibody.
Transcriptional regulators play a critical role in development by mediating tissue- and cell-specific transcription. POU domain factors are transcriptional regulators characterized by a bipartite DNA binding domain, which consists of two highly conserved regions, tethered by a variable linker of 14-26 amino acids. Pit-1, also known as growth hormone factor-1 (GHF-1), a member of the POU homeodomain family, is essential for the normal development of the anterior pituitary gland, where it is required for the formation of somatotropes, lactotropes and thyrotropes. In somatotropes and lactotropes, Pit-1 activates the production of growth hormone and Prolactin, respectively. In addition, Pit-1 acts as a repressor of gene expression, which allows for the differentiation of specific cell types. Pit-1 is expressed as two alternatively spliced products, designated Pit-1a and Pit-1b, which differ in their trans-activation ability. Mutations in the Pit-1 gene are believed to result in combined pituitary hormone deficiency (CPHD) for growth hormone, Prolactin and thyroid stimulating hormone. The gene which encodes Pit-1 maps to human chromosome 3p11.2.
Klonalität: Monoclonal
Klon-Bezeichnung: [PIT1/7262]
UniProt: P28069
Puffer: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reinheit: Protein A/G affinity
Formulierung: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Immunohistochemistry (FFPE): 1-2ug/ml
Anwendungsbeschreibung: Optimal dilution of the POU1F1 antibody should be determined by the researcher.